源语言 | 英语 |
---|---|
页(从-至) | 575-576 |
页数 | 2 |
期刊 | American Journal of Psychiatry |
卷 | 175 |
期 | 6 |
DOI | |
出版状态 | 已出版 - 6月 2018 |
!!!ASJC Scopus Subject Areas
- 精神病学和心理健康
联合国可持续发展目标
此成果有助于实现下列可持续发展目标:
访问文件
其它文件与链接
引用此
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
在: American Journal of Psychiatry, 卷 175, 号码 6, 06.2018, 页码 575-576.
科研成果: 期刊稿件 › 快报 › 同行评审
}
TY - JOUR
T1 - No association between antidepressant efficacy and rs28365143 in corticotropin-releasing hormone binding protein in a large meta-analysis
AU - Fabbri, Chiara
AU - Lewis, Cathryn M.
AU - Perlis, Roy H.
AU - Uher, Rudolf
N1 - Funding Information: The STAR*D study was supported by NIMH Contract N01MH90003 to the University of Texas Southwestern Medical Center (ClinicalTrials.gov identifier: NCT00021528). The GENDEP project was supported by a European Commission Framework 6 grant (contract reference: LSHB-CT-2003-503428). The Medical Research Council, United Kingdom, and GlaxoSmithKline (G0701420) provided support for genotyping. The NEWMEDS study was funded by the Innovative Medicine Initiative Joint Undertaking (IMI-JU) under grant agreement 115008, resources of which are from in-kind contributions from the European Union and the European Federation of Pharmaceutical Industries and Associations (EFPIA), as well as financial contribution from the European Union’s Seventh Framework Programme (FP7/2007-2013). EFPIA members Pfizer, GlaxoSmithKline, and F. Hoffmann–La Roche have contributed work and samples to the project presented here. The funders had no role in study design, data collection and analysis, the decision to publish, or in the preparation of the manuscript. The Pharmacogenomics Research Network Antidepressant Medication Pharmacogenomic Study (PGRN-AMPS) data set used for the analyses described in this letter was obtained from the dbGaP (study accession phs000670.v1.p1). The PGRN-AMPS was supported in part by NIH grants RO1 GM28157, U19 GM61388 (The Pharmacogenomics Research Network), U01 HG005137, R01 CA138461, and P20 1P20AA017830-01 (The Mayo Clinic Center for Individualized Treatment of Alcohol Dependence) and by a PhRMA Foundation Center of Excellence in Clinical Pharmacology award.
PY - 2018/6
Y1 - 2018/6
UR - http://www.scopus.com/inward/record.url?scp=85048069809&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85048069809&partnerID=8YFLogxK
U2 - 10.1176/appi.ajp.2018.18010070
DO - 10.1176/appi.ajp.2018.18010070
M3 - Letter
C2 - 29869543
AN - SCOPUS:85048069809
SN - 0002-953X
VL - 175
SP - 575
EP - 576
JO - American Journal of Psychiatry
JF - American Journal of Psychiatry
IS - 6
ER -